Lexaria Bioscience Corp
Research Lexaria Bioscience Corp (LEXX) on Bullrun: market cap USD 14.10M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerLEXX
- ExchangeNASDAQ
- CountryCanada
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 14.10M
- Financial periodFY2025
- RevenueUSD 705.92K
- Revenue growth52.0%
- Net income-USD 11.90M
- Free cash flow-USD 10.48M
- Gross margin99.6%
Valuation Snapshot
latest market cap is USD 14.10M.
About Lexaria Bioscience Corp
Lexaria Bioscience Corp. operates as a biotechnology company. The company offers its patented drug delivery-enabling platform technology, DehydraTECH, which combines active pharmaceutical ingredients (APIs) with specific long-chain fatty acid-rich triglyceride oils and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing for improved tolerability while promoting healthier oral ingestion methods.
Frequently asked questions
What is Lexaria Bioscience Corp's market cap?
Lexaria Bioscience Corp's market capitalization is USD 14.10M.
What does Lexaria Bioscience Corp do?
Lexaria Bioscience Corp. operates as a biotechnology company. The company offers its patented drug delivery-enabling platform technology, DehydraTECH, which combines active pharmaceutical ingredients (APIs) with specific long-chain fatty acid-rich triglyceride oils and carrier compounds that...